Burzynski Research Institute Inc (BZYR) - Financial and Strategic SWOT Analysis Review

July 2021 | 28 pages | ID: BCA5FDDBE08EN
GlobalData

Abstracts

Burzynski Research Institute Inc (BZYR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Burzynski Research Institute Inc (BRI) is a biopharmaceutical company involved in developing cancer therapies based on the principles of genome and epigenomic. The company focuses on the identification, production, marketing, promotion and sale of medical chemical compounds composed of growth-inhibiting peptides, organic acids and amino acid derivatives. Its product portfolio consists of antineoplastons, namely, A10 and AS2-1, evaluated in Phase III clinical trial for the treatment of cancer. The company also examines pharmacokinetics and pharmacodynamics of antineoplastons in patients with neoplastic disease, and offers consulting services. It has a research facility in Stafford, Texas. BRI is headquartered in Houston, Texas, the US.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Burzynski Research Institute Inc - Key Facts
Burzynski Research Institute Inc - Key Employees
Burzynski Research Institute Inc - Key Employee Biographies
Burzynski Research Institute Inc - Major Products and Services
Burzynski Research Institute Inc - History
Burzynski Research Institute Inc - Company Statement
Burzynski Research Institute Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Burzynski Research Institute Inc - Business Description
R&D Overview
Burzynski Research Institute Inc - SWOT Analysis
SWOT Analysis - Overview
Burzynski Research Institute Inc - Strengths
Burzynski Research Institute Inc - Weaknesses
Burzynski Research Institute Inc - Opportunities
Burzynski Research Institute Inc - Threats
Burzynski Research Institute Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Burzynski Research Institute Inc, Key Facts
Burzynski Research Institute Inc, Key Employees
Burzynski Research Institute Inc, Key Employee Biographies
Burzynski Research Institute Inc, Major Products and Services
Burzynski Research Institute Inc, History
Burzynski Research Institute Inc, Other Locations
Burzynski Research Institute Inc, Key Competitors
Burzynski Research Institute Inc, Ratios based on current share price
Burzynski Research Institute Inc, Annual Ratios
Burzynski Research Institute Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Burzynski Research Institute Inc, Performance Chart (2017 - 2021)
Burzynski Research Institute Inc, Ratio Charts